Clinical Chemistry AACC Online Job Center
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Clinical Chemistry 47: 412-417, 2001;
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit an electronic Letter to
the Editor about this paper
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (50)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ooi, D. S.
Right arrow Articles by Wells, G. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ooi, D. S.
Right arrow Articles by Wells, G. A.
Related Collections
Right arrow Evidence Based Laboratory Medicine and Test Utilization
Right arrow Proteomics and Protein Markers
Right arrow Heart Health and the Clinical Laboratory
(Clinical Chemistry. 2001;47:412-417.)
© 2001 American Association for Clinical Chemistry, Inc.


Articles

Cardiac Troponin T Predicts Long-Term Outcomes in Hemodialysis Patients

Daylily S. Ooi1,4,a, Deborah Zimmerman2,5, Janet Graham2 and George A. Wells3,5

1 Divisions of Biochemistry and
2 Nephrology, Ottawa Hospital–Civic Campus, 1053 Carling Ave., Ottawa, ON K1Y 4E9 Canada.

3 Departments of Epidemiology and Community Medicine,
4 Pathology, and
5 Medicine, University of Ottawa, Ottawa, ON K1H 8M5, Canada.
a Address correspondence to this author at: Division of Biochemistry, Department of Pathology and Laboratory Medicine, Ottawa Hospital–Civic Campus, 1053 Carling Ave., Ottawa, ON K1Y 4E9 Canada. Fax 613-761-5401; e-mail dsooi{at}ottawahospital.on.ca.

Background: Increased plasma troponin T (cTnT), but not troponin I (cTnI), is frequently observed in end-stage renal failure patients. Although generally considered spurious, we previously reported an associated increased mortality at 12 months.

Methods: We studied long-term outcomes in 244 patients on chronic hemodialysis for up to 34 months, correlating the outcomes to plasma cTnT in routine predialysis samples. In addition, subsequent plasma samples at least 1 year later and within 6 months of data analysis were available in 97 patients and were used to identify patients with increasing plasma cTnT. The endpoints used were death and new or worsening coronary, cerebro-, and peripheral vascular disease and neuropathy.

Results: Transplantation occurred more frequently in patients with low initial cTnT: 31%, 13%, and 3% in the groups with cTnT <0.010, 0.010–0.099, and >=0.100 µg/L, respectively. In the same groups, total deaths occurred in 6%, 43%, and 59% and cardiac deaths in 0%, 14%, and 24% of patients. In patients with follow-up samples, the group with increasing cTnT had a significantly increased death (relative risk, 2.0; P = 0.028). The increase was mainly in cardiac and sudden deaths.

Conclusions: Higher plasma cTnT predicts long-term all-cause mortality in hemodialysis patients, even at concentrations <0.100 µg/L, as does an increasing cTnT concentration over time.




The following articles in journals at HighWire Press have cited this article:


Home page
Nephrol Dial TransplantHome page
G. M. Connolly, R. Cunningham, P. T. McNamee, I. S. Young, and A. P. Maxwell
Troponin T is an independent predictor of mortality in renal transplant recipients
Nephrol. Dial. Transplant., March 1, 2008; 23(3): 1019 - 1025.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
A. Yee-Moon Wang, C. Wai-Kei Lam, M. Wang, I. Hiu-Shuen Chan, W. B. Goggins, C.-M. Yu, S.-F. Lui, and J. E Sanderson
Prognostic Value of Cardiac Troponin T Is Independent of Inflammation, Residual Renal Function, and Cardiac Hypertrophy and Dysfunction in Peritoneal Dialysis Patients
Clin. Chem., May 1, 2007; 53(5): 882 - 889.
[Abstract] [Full Text] [PDF]


Home page
HeartHome page
R Sharma, D C Gaze, D Pellerin, R L Mehta, H Gregson, C P Streather, P O Collinson, and S J D Brecker
Cardiac structural and functional abnormalities in end stage renal disease patients with elevated cardiac troponin T
Heart, June 1, 2006; 92(6): 804 - 809.
[Abstract] [Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
B. Conway, M. McLaughlin, P. Sharpe, and J. Harty
Use of cardiac troponin T in diagnosis and prognosis of cardiac events in patients on chronic haemodialysis
Nephrol. Dial. Transplant., December 1, 2005; 20(12): 2759 - 2764.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
N. A. Khan, B. R. Hemmelgarn, M. Tonelli, C. R. Thompson, and A. Levin
Prognostic Value of Troponin T and I Among Asymptomatic Patients With End-Stage Renal Disease: A Meta-Analysis
Circulation, November 15, 2005; 112(20): 3088 - 3096.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
N. A. Abbas, R. I. John, M. C. Webb, M. E. Kempson, A. N. Potter, C. P. Price, S. Vickery, and E. J. Lamb
Cardiac Troponins and Renal Function in Nondialysis Patients with Chronic Kidney Disease
Clin. Chem., November 1, 2005; 51(11): 2059 - 2066.
[Abstract] [Full Text] [PDF]


Home page
Eur J EchocardiogrHome page
H.H.H. Feringa, J.J. Bax, O. Schouten, and D. Poldermans
Ischemic heart disease in renal transplant candidates: Towards non-invasive approaches for preoperative risk stratification
Eur J Echocardiogr, October 1, 2005; 6(5): 313 - 316.
[Abstract] [Full Text] [PDF]


Home page
Eur J EchocardiogrHome page
R. Sharma, D. Pellerin, D.C. Gaze, J.S. Shah, C.P. Streather, P.O. Collinson, and S.J. Brecker
Dobutamine stress echocardiography and cardiac troponin T for the detection of significant coronary artery disease and predicting outcome in renal transplant candidates
Eur J Echocardiogr, October 1, 2005; 6(5): 327 - 335.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
J. Ishii, W. Cui, F. Kitagawa, T. Kuno, Y. Nakamura, H. Naruse, Y. Mori, T. Ishikawa, Y. Nagamura, T. Kondo, et al.
Prognostic Value of Combination of Cardiac Troponin T and B-Type Natriuretic Peptide after Initiation of Treatment in Patients with Chronic Heart Failure
Clin. Chem., December 1, 2003; 49(12): 2020 - 2026.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
R. Ziebig, A. Lun, B. Hocher, F. Priem, C. Altermann, G. Asmus, H. Kern, R. Krause, B. Lorenz, R. Mobes, et al.
Renal Elimination of Troponin T and Troponin I
Clin. Chem., July 1, 2003; 49(7): 1191 - 1193.
[Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
M. Beciani, A. Tedesco, A. Violante, S. Cipriani, M. Azzarito, A. Sturniolo, and G. Splendiani
Cardiac troponin I (2nd generation assay) in chronic haemodialysis patients: prevalence and prognostic value
Nephrol. Dial. Transplant., May 1, 2003; 18(5): 942 - 946.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
B. J. Freda, W. H. W. Tang, F. Van Lente, W. F. Peacock, and G. S. Francis
Cardiac troponins in renal insufficiency: Review and clinical implications
J. Am. Coll. Cardiol., December 18, 2002; 40(12): 2065 - 2071.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
F. S. Apple, M. M. Murakami, L. A. Pearce, and C. A. Herzog
Predictive Value of Cardiac Troponin I and T for Subsequent Death in End-Stage Renal Disease
Circulation, December 3, 2002; 106(23): 2941 - 2945.
[Abstract] [Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
C. Lowbeer, A. Gutierrez, S. A. Gustafsson, R. Norrman, J. Hulting, and A. Seeberger
Elevated cardiac troponin T in peritoneal dialysis patients is associated with CRP and predicts all-cause mortality and cardiac death
Nephrol. Dial. Transplant., December 1, 2002; 17(12): 2178 - 2183.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2001 by the American Association for Clinical Chemistry.